Indonesia remains growth market for Pharmaniaga


Pharmaniaga group managing director Datuk Zulkarnain Md Eusope

PETALING JAYA: Pharmaniaga Bhd expects to drive sales through its focus on growth opportunities in Indonesia and the private market in Malaysia while awaiting for the extension of its logistics and distribution agreement with the Health Ministry.

The logistic and distribution agreement is targeted to be executed in the fourth quarter of 2022, the pharmaceutical company said in a filing with Bursa Malaysia yesterday.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Local market treads water
Heralding the Golden Age of Crypto
Governance challenges continue at TMC Life after CEO’s removal
Macquarie bidding for Axiata’s EDOTCO
SAILH set to propel logistics sector
TNB commences RE supply to Singapore
Dassault Aviation flying high in Malaysia
Yinson confident of strong FY25 performance
Buckle up for a bumpy 2025
Latest chart-topper at auctions

Others Also Read